Literature DB >> 12540856

Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.

Kwok-Kin Wong1, Richard S Maser, Robert M Bachoo, Jayant Menon, Daniel R Carrasco, Yansong Gu, Frederick W Alt, Ronald A DePinho.   

Abstract

Ataxia-telangiectasia (A-T) results from the loss of ataxia-telangiectasia mutated (Atm) function and is characterized by accelerated telomere loss, genomic instability, progressive neurological degeneration, premature ageing and increased neoplasia incidence. Here we evaluate the functional interaction of Atm and telomeres in vivo. We examined the impact of Atm deficiency as a function of progressive telomere attrition at both the cellular and whole-organism level in mice doubly null for Atm and the telomerase RNA component (Terc). These compound mutants showed increased telomere erosion and genomic instability, yet they experienced a substantial elimination of T-cell lymphomas associated with Atm deficiency. A generalized proliferation defect was evident in all cell types and tissues examined, and this defect extended to tissue stem/progenitor cell compartments, thereby providing a basis for progressive multi-organ system compromise, accelerated ageing and premature death. We show that Atm deficiency and telomere dysfunction act together to impair cellular and whole-organism viability, thus supporting the view that aspects of A-T pathophysiology are linked to the functional state of telomeres and its adverse effects on stem/progenitor cell reserves.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540856     DOI: 10.1038/nature01385

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  130 in total

Review 1.  Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence?

Authors:  Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  DNA damage checkpoint kinase Chk2 triggers replicative senescence.

Authors:  Véronique Gire; Pierre Roux; David Wynford-Thomas; Jean-Marc Brondello; Vjekoslav Dulic
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

Review 3.  Telomeres and telomerase.

Authors:  Simon R W L Chan; Elizabeth H Blackburn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-01-29       Impact factor: 6.237

4.  Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction.

Authors:  Tobias Sperka; Zhangfa Song; Yohei Morita; Kodandaramireddy Nalapareddy; Luis Miguel Guachalla; André Lechel; Yvonne Begus-Nahrmann; Martin D Burkhalter; Monika Mach; Falk Schlaudraff; Birgit Liss; Zhenyu Ju; Michael R Speicher; K Lenhard Rudolph
Journal:  Nat Cell Biol       Date:  2011-12-04       Impact factor: 28.824

5.  Global heterochromatin loss: a unifying theory of aging?

Authors:  Amy Tsurumi; Willis X Li
Journal:  Epigenetics       Date:  2012-07-01       Impact factor: 4.528

Review 6.  Origin of chromosomal translocations in lymphoid cancer.

Authors:  André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

7.  Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation.

Authors:  Christina Y Soohoo; Rong Shi; Tae Ho Lee; Pengyu Huang; Kun Ping Lu; Xiao Zhen Zhou
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

Review 8.  Chromatin regulation and genome maintenance by mammalian SIRT6.

Authors:  Ruth I Tennen; Katrin F Chua
Journal:  Trends Biochem Sci       Date:  2010-08-21       Impact factor: 13.807

Review 9.  Cellular mechanisms of somatic stem cell aging.

Authors:  Yunjoon Jung; Andrew S Brack
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

10.  ATM regulates the length of individual telomere tracts in Arabidopsis.

Authors:  Laurent Vespa; Ross T Warrington; Petr Mokros; Jiri Siroky; Dorothy E Shippen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.